1780TiP A phase II clinical study to assess efficacy of induction ipilimumab/nivolumab to spare the bladder in urothelial bladder cancer (INDI-BLADE). - Stockem, C.F.; van Rhijn, B.W.G.; Boellaard, T.; van Montfoort, M.L.; Balduzzi, S.; Boormans, J.; Franckena, M.; Meijer, R.; Noteboom, J.; Robbrecht, D.; Suelmann, B.B.; Schaake, E.; et al. (Annals of Oncology, 2022)